Oleanolic acid potentiates the antileukemic activity of elesclomol by promoting FDX1-mediated cuproptosis
Cuproptosis is a programmed cell death in leukemia cell therapy. Elesclomol(ES) as a copper ion carrier, triggers cuproptosis in malignant cells and displays antitumor potential. Oleanolic acid(OA) has garnered attention in hematologic malignancies recent years. The two compounds can synergistically regulate cuproptosis remains unclear. The present study aimed to determine whether OA augments ES-induced cuproptosis in leukemia cells. Cell viability and proliferation were assessed using CCK-8, colony formation, and EdU assays. Expression of the cuproptosis regulators FDX1, DLAT, and DLST was profiled by RT-qPCR, Western blot. The functional relevance of the FDX1/DLAT axis was interrogated through FDX1 knockdown and DLAT overexpression. In vivo was assessed in nude mice. Proliferation assays demonstrated that OA reinforced the growth-inhibitory action of ES on leukemia cells. Molecular analyses revealed that FDX1 silencing or DLAT overexpression markedly attenuated the effects elicited by OA, supporting the involvement of the FDX1/DLAT axis in OA-mediated potentiation of cuproptosis. In the K562 xenograft model, co-administration of OA and ES yielded greater reductions in tumor size, volume, and weight. By upregulating FDX1 and promoting protein lipoylation, OA synergistically induces cuproptosis in K562 and HL-60 cells, offering a candidate target and therapeutic strategy for leukemia.
Authors
- Linlin Song (ORCID: https://orcid.org/0009-0006-6303-8075)
- Liru Zhang (ORCID: https://orcid.org/0000-0002-6911-4685)
- Liping Sun
- He Teng
- Xuebin Gao
- Hong Zhao
- Wenhang Li
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-80328-0
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00